Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
S. Korea to extend R&D support for bio convergence tech, medical devices
By YonhapPublished : Jan. 29, 2021 - 10:49
South Korea's science ministry said Friday it will extend research and development (R&D) support for the bio-health sector, bolstering efforts to develop regenerative medicine and homegrown medical devices.
Under the Ministry of Science and ICT's bio-health strategy, the country will also expand R&D investment to converge cutting-edge technology, such as artificial intelligence, with new medicine development to boost efficiency.
The ministry will also expand support for the development of homegrown medical devices.
It will also aim to acquire core technology in next-generation regenerative medicine, such as stem cell research, and strengthen long-term support for new treatment methods, such as gene editing technology.
The move comes after the country outlined a bio-health investment strategy in 2019, which only clarified support for four sectors -- fundamental research, medicine, health care services and regulatory science.
The updated strategy includes support for bio-convergence technology, medical devices, regenerative medicine, clinical health science, bio-resources and information infrastructure, as well as fostering more experts.
The science ministry has set aside 520 billion won ($466 million) to support biotechnology development this year. (Yonhap)
Under the Ministry of Science and ICT's bio-health strategy, the country will also expand R&D investment to converge cutting-edge technology, such as artificial intelligence, with new medicine development to boost efficiency.
The ministry will also expand support for the development of homegrown medical devices.
It will also aim to acquire core technology in next-generation regenerative medicine, such as stem cell research, and strengthen long-term support for new treatment methods, such as gene editing technology.
The move comes after the country outlined a bio-health investment strategy in 2019, which only clarified support for four sectors -- fundamental research, medicine, health care services and regulatory science.
The updated strategy includes support for bio-convergence technology, medical devices, regenerative medicine, clinical health science, bio-resources and information infrastructure, as well as fostering more experts.
The science ministry has set aside 520 billion won ($466 million) to support biotechnology development this year. (Yonhap)
